Skip to main content
Researchers have identified genetic biomarkers that indicate whether a person will respond favorably to specific antidepressant medications. A separate research finding identified a genetic switch implicated in cognitive problems associated with depression. The work with genetic biomarkers found that after eight weeks of treatment, the patients who had not responded were those who had higher levels of three inflammation markers before treatment started than patients who responded. The biomarkers are not specific to one or the other antidepressants, so could not be used to guide the choice of antidepressants, but could identify patients that potentially may be . . .
Content Restricted

This article is reserved for members with an active Standard Membership. Please purchase a Standard Membership to view this resource.

Purchase A Standard Account

Tagged As:

Login to access The OPEN MINDS Circle Library. Not a member? Create your free account now!


Support Request

Need help now?

Call our toll-free phone number 877-350-6463